Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,900
Closed -$450K 1412
2021
Q2
$450K Sell
6,900
-3,000
-30% -$190K ﹤0.01% 1089
2021
Q1
$520K Hold
9,900
﹤0.01% 1020
2020
Q4
$442K Buy
9,900
+1,000
+11% +$34.5K ﹤0.01% 1022
2020
Q3
$258K Buy
8,900
+1,000
+13% +$31.4K ﹤0.01% 1006
2020
Q2
$281K Buy
7,900
+2,000
+34% +$84.3K ﹤0.01% 949
2020
Q1
$305K Hold
5,900
﹤0.01% 933
2019
Q4
$403K Sell
5,900
-1,000
-14% -$62.7K ﹤0.01% 961
2019
Q3
$331K Hold
6,900
﹤0.01% 999
2019
Q2
$461K Buy
+6,900
New +$525K ﹤0.01% 993

Other funds holding INGN

Gabelli Funds's INGN Position: Q3 2021 in Review

Gabelli Funds sold out of Inogen (INGN) in Q3 2021, closing a stake of 6,900 shares — an estimated $450K sold.

Gabelli Funds first reported a position in INGN in Q2 2019 and held it in 9 quarters. The position peaked at $520K in Q1 2021. 170 funds tracked by Wall St. Rank hold INGN as of Q3 2021.

  • Gabelli Funds reported no remaining Inogen position as of Q3 2021 after selling out during the quarter.
  • Gabelli Funds sold 6,900 Inogen shares in Q3 2021, an estimated $450K.
  • Gabelli Funds first reported a position in Inogen in Q2 2019 and held it in 9 quarters.
  • Gabelli Funds's Inogen position peaked at $520K in Q1 2021.
  • 170 funds tracked by Wall St. Rank held Inogen as of Q3 2021.

Based on Gabelli Funds's 13F filing for Q3 2021, filed 12 Nov 2021.